Hyperfine, Inc. (HYPR): Price and Financial Metrics

Hyperfine, Inc. (HYPR): $1.19

0.01 (+0.85%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

F

HYPR Price/Volume Stats

Current price $1.19 52-week high $3.28
Prev. close $1.18 52-week low $0.91
Day low $1.18 Volume 67,900
Day high $1.26 Avg. volume 58,353
50-day MA $1.07 Dividend yield N/A
200-day MA $1.66 Market Cap 85.20M

HYPR Stock Price Chart Interactive Chart >

HYPR POWR Grades

  • Sentiment is the dimension where HYPR ranks best; there it ranks ahead of 91.48% of US stocks.
  • The strongest trend for HYPR is in Growth, which has been heading down over the past 26 weeks.
  • HYPR ranks lowest in Quality; there it ranks in the 2nd percentile.

HYPR Stock Summary

  • For HYPR, its debt to operating expenses ratio is greater than that reported by just 0.22% of US equities we're observing.
  • HYPR's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 8.84% of US stocks.
  • As for revenue growth, note that HYPR's revenue has grown 67.7% over the past 12 months; that beats the revenue growth of 93.32% of US companies in our set.
  • Stocks that are quantitatively similar to HYPR, based on their financial statements, market capitalization, and price volatility, are GPRO, SCKT, HCWB, PDEX, and KOPN.
  • To dig deeper into the stock's financial statements, go to HYPR's page on browse-edgar?action=getcompany&CIK=0001833769.

HYPR Valuation Summary

  • In comparison to the median Healthcare stock, HYPR's price/sales ratio is 272.73% higher, now standing at 8.2.
  • HYPR's EV/EBIT ratio has moved up 8.3 over the prior 36 months.

Below are key valuation metrics over time for HYPR.

Stock Date P/S P/B P/E EV/EBIT
HYPR 2023-12-29 8.2 0.9 -1.7 0.1
HYPR 2023-12-28 8.0 0.8 -1.7 0.2
HYPR 2023-12-27 7.8 0.8 -1.6 0.2
HYPR 2023-12-26 7.5 0.8 -1.6 0.3
HYPR 2023-12-22 8.1 0.8 -1.7 0.2
HYPR 2023-12-21 7.8 0.8 -1.6 0.2

Hyperfine, Inc. (HYPR) Company Bio


Hyperfine, Inc. operates as a medical imaging device company. It offers Swoop system, a portable magnetic resonance imaging system. The company was founded in 2014 and is based in Guilford, Connecticut.


HYPR Latest News Stream


Event/Time News Detail
Loading, please wait...

HYPR Latest Social Stream


Loading social stream, please wait...

View Full HYPR Social Stream

Latest HYPR News From Around the Web

Below are the latest news stories about HYPERFINE INC that investors may wish to consider to help them evaluate HYPR as an investment opportunity.

Hyperfine, Inc. Announces Presentations on Clinical Advancements at RSNA 2023

GUILFORD, Conn., November 20, 2023--Hyperfine, Inc. announces presentations on clinical advancements at RSNA 2023

Yahoo | November 20, 2023

Hyperfine, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference

GUILFORD, Conn., November 16, 2023--Hyperfine, Inc. to present at the Piper Sandler 35th annual healthcare conference.

Yahoo | November 16, 2023

Hyperfine, Inc. (NASDAQ:HYPR) Q3 2023 Earnings Call Transcript

Hyperfine, Inc. (NASDAQ:HYPR) Q3 2023 Earnings Call Transcript November 10, 2023 Operator: Good afternoon, and welcome to Hyperfine’s Third Quarter 2023 Earnings Conference Call. Currently, all participants are in a listen-only mode. We will be facilitating a question-and-answer session towards the end of today’s call. As a reminder, this call is being recorded for replay […]

Yahoo | November 12, 2023

Hyperfine, Inc. Reports Third Quarter 2023 Financial Results

GUILFORD, Conn., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system—the Swoop® system—today announced third quarter 2023 financial results and provided a business update. “We remain focused on our three strategic pillars of innovation, clinical evidence, and commercialization, all while actively managing o

Yahoo | November 9, 2023

Observational Study Finds That Hyperfine, Inc. Portable MR Brain Imaging System Assists Clinicians in Early Detection of Acute Brain Injury in ECMO Patients

GUILFORD, Conn., November 02, 2023--Observational study finds that Hyperfine, Inc. portable MR brain imaging system assists clinicians in early detection of ABI in ECMO patients

Yahoo | November 2, 2023

Read More 'HYPR' Stories Here

HYPR Price Returns

1-mo 7.21%
3-mo 13.33%
6-mo -40.20%
1-year -15.00%
3-year -88.04%
5-year N/A
YTD 6.25%
2023 33.33%
2022 -88.41%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!